Your browser doesn't support javascript.
loading
The socioeconomic impact of cancer on patients and their relatives: Organisation of European Cancer Institutes task force consensus recommendations on conceptual framework, taxonomy, and research directions.
Schlander, Michael; van Harten, Wim; Retèl, Valesca P; Pham, Phu Duy; Vancoppenolle, Julie M; Ubels, Jasper; López, Olaya Seoane; Quirland, Camila; Maza, Felipe; Aas, Eline; Crusius, Bernd; Escobedo, Agustín; Franzen, Nora; Fuentes-Cid, Jeanette; Hernandez, Diego; Hernandez-Villafuerte, Karla; Kirac, Iva; Paty, Artus; Philip, Thierry; Smeland, Sigbjørn; Sullivan, Richard; Vanni, Elena; Varga, Sinisa; Vermeulin, Thomas; Eckford, Rachel D.
Affiliation
  • Schlander M; Division of Health Economics, German Cancer Research Center (DKFZ), Heidelberg, Germany; Mannheim Medical Faculty, University of Heidelberg, Mannheim, Germany; Alfred Weber Institute (AWI), University of Heidelberg, Mannheim, Germany; Institute for Innovation & Valuation (InnoVal(HC)), Wiesbaden
  • van Harten W; Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Health Technology and Services Research, University of Twente, Enschede, Netherlands; Rijnstate Hospital, Arnhem, Netherlands.
  • Retèl VP; Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, Netherlands; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, Netherlands.
  • Pham PD; Division of Health Economics, German Cancer Research Center (DKFZ), Heidelberg, Germany; Mannheim Medical Faculty, University of Heidelberg, Mannheim, Germany.
  • Vancoppenolle JM; Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Health Technology and Services Research, University of Twente, Enschede, Netherlands.
  • Ubels J; Division of Health Economics, German Cancer Research Center (DKFZ), Heidelberg, Germany; Mannheim Medical Faculty, University of Heidelberg, Mannheim, Germany.
  • López OS; The Support Team, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Quirland C; Health Technology Assessment Unit, Arturo López Perez Foundation, Santiago, Chile; School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Maza F; Health Technology Assessment Unit, Arturo López Perez Foundation, Santiago, Chile.
  • Aas E; Department of Health Management and Health Economics, University of Oslo, Oslo, Norway; Division of Health Services, Norwegian Institute of Public Health, Oslo, Norway.
  • Crusius B; Federal Cancer Patient Aid, Bonn, Germany.
  • Escobedo A; Oncology Care Management, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Franzen N; Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Fuentes-Cid J; Cancer Research Department, Arturo López Perez Foundation, Santiago, Chile.
  • Hernandez D; Division of Health Economics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hernandez-Villafuerte K; Division of Health Economics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Kirac I; Genetic Counseling Unit, University Hospital for Tumors, Sestre Milosrdnice University Hospital Center, Zagreb, Croatia.
  • Paty A; Department of Medical Information, Centre Henri Becquerel, Rouen, France.
  • Philip T; Organisation of European Cancer Institutes (OECI), Brussels, Belgium; Institut Curie, Paris, France.
  • Smeland S; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Division of Cancer Medicine, Oslo University Hospital Comprehensive Cancer Centre, Oslo, Norway.
  • Sullivan R; Institute of Cancer Policy, King's College London, London, UK.
  • Vanni E; Business Controlling, Humanitas Clinical and Research Center, Milan, Italy; Biomedical Sciences, Humanitas Clinical and Research Center, Milan, Italy.
  • Varga S; Institute for Gastroenterological Tumours, Zagreb, Croatia.
  • Vermeulin T; Department of Medical Information, Centre Henri Becquerel, Rouen, France.
  • Eckford RD; Division of Health Economics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Lancet Oncol ; 25(4): e152-e163, 2024 Apr.
Article in En | MEDLINE | ID: mdl-38547899
ABSTRACT
Loss of income and out-of-pocket expenditures are important causes of financial hardship in many patients with cancer, even in high-income countries. The far-reaching consequences extend beyond the patients themselves to their relatives, including caregivers and dependents. European research to date has been limited and is hampered by the absence of a coherent theoretical framework and by heterogeneous methods and terminology. To address these shortages, a task force initiated by the Organisation of European Cancer Institutes (OECI) produced 25 recommendations, including a comprehensive definition of socioeconomic impact from the perspective of patients and their relatives, a conceptual framework, and a consistent taxonomy linked to the framework. The OECI task force consensus statement highlights directions for future research with a view towards policy relevance. Beyond descriptive studies into the dimension of the problem, individual severity and predictors of vulnerability should be explored. It is anticipated that the consensus recommendations will facilitate and enhance future research efforts into the socioeconomic impact of cancer and cancer care, providing a crucial reference point for the development and validation of patient-reported outcome instruments aimed at measuring its broader effects.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Neoplasms Limits: Humans Language: En Year: 2024 Type: Article

Full text: 1 Database: MEDLINE Main subject: Neoplasms Limits: Humans Language: En Year: 2024 Type: Article